ETF PRO AINovember 17, 2026
IDNA iShares Genomics Immunology and Healthcare ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.47%expense ratio
$340Mfund assets
+49.9%return, YTD
—return, 1 year
+$36Mnet flow, 1 month
+$138Mnet flow, 1 year
31.1%realized volatility, 1y
-11.1%worst drawdown, 1y
Top ten holdings
| 1 | MRNA MODERNA | 13.74% |
| 2 | TWST TWIST BIOSCIENCE | 4.71% |
| 3 | REGN REGENERON PHARMACEUTICALS | 4.39% |
| 4 | EXEL EXELIXIS | 3.82% |
| 5 | VRTX VERTEX PHARMACEUTICALS | 3.52% |
| 6 | MRK MERCK & CO | 3.57% |
| 7 | INCY INCYTE | 3.45% |
| 8 | RVMD REVOLUTION MEDICINES | 3.37% |
| 9 | BNTX BIONTECH SE | 2.84% |
| 10 | IOVA IOVANCE BIOTHERAPEUTICS | 2.76% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS